OBJECTIVE To validate the global features of postoperative adverse outcomes for surgical patients with schizophrenia. BACKGROUND Patients with schizophrenia were known to have a higher risk of complications during hospitalization. Quality of care has become the key factor in reducing their potential mortality afterwards. METHODS We present a population-based study of 8967 schizophrenic pati...

conclusions the present study supported the contamination with t. gondii as a risk factor for schizophrenia just in women. results the analyses confirmed the significant differences between healthy women and ones with schizophrenia (p = 0.001) as well as between males and females with schizophrenia (p = 0.009) in igg positivity. materials and methods t. gondii igg antibodies of 100 patients wit...

BACKGROUND Several clinical practice guidelines suggest using atypical over typical antipsychotics in patients diagnosed with schizophrenia. Nevertheless, cost-containment policy urged restricting usage of atypical antipsychotics and switching from atypical to typical antipsychotics. OBJECTIVE This study aimed to evaluate clinical and economic impacts of switching from atypical to typical ant...

Non-adherence to antipsychotic medication and hospitalization in psychotic disorders are common and costly problems. Our aim was to identify risk factors for rehospitalization of patients with recent onset schizophrenia or schizoaffective disorder in a population-based cohort study. All patients with a first hospitalization for schizophrenia or schizoaffective disorder between 2006 and 2007 wer...

Introduction Schizophrenia patients are at an increased risk for severe SARS-CoV-2 illness. Recent studies indicate that vaccines reduce morbidity gaps between schizophrenia and the general population; nonetheless, ongoing emergence of COVID-19 variants frequency breakthrough infections might lead to changes in these profiles. Objectives In this study we aimed bridge gap by assessing infection,...

Relapse in patients with schizophrenia has devastating repercussions, including worsening symptoms, impaired functioning, cognitive deterioration and reduced quality of life. This progressive decline exacerbates the burden of illness on patients and their families. Relapse prevention is identified as a key therapeutic aim; however, the absence of widely accepted relapse definition criteria cons...

CONTEXT Consistent evidence indicates that some, but not most, patients with schizophrenia have below-average intelligence years before they manifest psychosis. However, it is not clear whether this below-average premorbid intelligence is stable or progressive. OBJECTIVE To examine whether increased risk for schizophrenia is associated with declining intellectual performance from childhood th...

BACKGROUND: Decreasing hospital admissions is important for improving outcomes for people with schizophrenia and for reducing cost of hospitalization, the largest expenditure in treating this persistent and severe mental illness. This prospective observational study compared olanzapine and risperidone on one-year psychiatric hospitalization rate, duration, and time to hospitalization in the tre...